The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge
about
Structure-based analysis of the herpes simplex virus glycoprotein D binding site present on herpesvirus entry mediator HveA (HVEM).Bimolecular complementation defines functional regions of Herpes simplex virus gB that are involved with gH/gL as a necessary step leading to cell fusionHerpes simplex virus glycoprotein B associates with target membranes via its fusion loopsSpecific association of glycoprotein B with lipid rafts during herpes simplex virus entryStuck in the middle: structural insights into the role of the gH/gL heterodimer in herpesvirus entryReevaluating herpes simplex virus hemifusion.Anti-glycoprotein H antibody impairs the pathogenicity of varicella-zoster virus in skin xenografts in the SCID mouse model.Herpes simplex virus tegument ICP0 is capsid associated, and its E3 ubiquitin ligase domain is important for incorporation into virions.Insertion mutations in herpes simplex virus 1 glycoprotein H reduce cell surface expression, slow the rate of cell fusion, or abrogate functions in cell fusion and viral entry.In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model.Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEMHerpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry.Functional region IV of glycoprotein D from herpes simplex virus modulates glycoprotein binding to the herpesvirus entry mediatorStructural and antigenic analysis of a truncated form of the herpes simplex virus glycoprotein gH-gL complex.DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivoRecent progress in herpes simplex virus immunobiology and vaccine researchHSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.Capturing the herpes simplex virus core fusion complex (gB-gH/gL) in an acidic environment.Herpes virus fusion and entry: a story with many characters.Intravaginal Zinc Oxide Tetrapod Nanoparticles as Novel Immunoprotective Agents against Genital Herpes.Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humansBimolecular complementation reveals that glycoproteins gB and gH/gL of herpes simplex virus interact with each other during cell fusion.Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig.Structure-function analysis of herpes simplex virus type 1 gD and gH-gL: clues from gDgH chimerasHerpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine.Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface.Cellular and viral requirements for rapid endocytic entry of herpes simplex virus.Seroprevalence of Herpes Simplex Virus Type 1 and 2 in Taiwan and Risk Factor Analysis, 2007.N-terminal mutants of herpes simplex virus type 2 gH are transported without gL but require gL for functionPatient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.Human Cytomegalovirus gH/gL Forms a Stable Complex with the Fusion Protein gB in Virions.Regulation of herpes simplex virus gB-induced cell-cell fusion by mutant forms of gH/gL in the absence of gD and cellular receptors.Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virusExploiting herpes simplex virus entry for novel therapeutics.Early events in herpes simplex virus lifecycle with implications for an infection of lifetimeUse of baculovirus-expressed glycoprotein H in an enzyme-linked immunosorbent assay developed to assess exposure to chelonid fibropapillomatosis-associated herpesvirus and its relationship to the prevalence of fibropapillomatosis in sea turtles.Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB.The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates.Herpes simplex virus Membrane Fusion.A heptad repeat in herpes simplex virus 1 gH, located downstream of the alpha-helix with attributes of a fusion peptide, is critical for virus entry and fusion.
P2860
Q24538731-FD9C7D2B-1AC3-4883-AA8D-FE7490CE9FD1Q24604871-AF6DDEC6-3BF2-4FE8-A77B-3736456F3819Q24644405-8B3F41B7-74DF-4570-A4CB-E9F5FF3722B6Q24683262-35AB24B6-509B-4F17-ACE4-8B882DA52752Q26995393-2ECE85CD-A8A1-4A2E-850A-23AC9E65C076Q30432548-9D6DA648-3D7D-4F6F-BB83-61F62B750117Q33558564-23977C62-8BFC-487C-B44E-88471956401EQ33614341-A57EFBC1-AC31-44D7-B3EE-92DD7926BE21Q33614527-DEE0D153-91C8-42F2-B379-9C6D1D82F420Q33639596-7A12239D-FE4B-4059-AC85-7E41CE17083EQ33782593-4758F5B6-326C-4DA3-8D69-9FBCE829D036Q33783740-BED2C3A1-8056-4152-9AE6-41A2ACB21902Q33783757-4DB6EBB4-8691-4309-B21F-A86D024DE6BDQ33785730-FE1D84BB-B844-4BA3-80DA-8321CD88AAB1Q33827001-1786143E-A6DF-4A18-96FD-5625E4F53A0CQ33963713-0FA24B7D-ED4A-4E35-9E50-3FFCD16093BEQ33995747-8369A7E4-BC7D-4E49-90F2-E8596077C128Q34179684-94B4D170-2E27-4089-821E-2C085241C486Q34285628-C07E80D9-6B26-4B60-B22A-0661E4A84B2CQ34526716-E105A8B5-608F-4432-8132-C6272E8B2006Q34593833-D7AEB2FB-C2CB-4C4B-A970-8ACC6951B7F2Q34713747-134A73AB-C469-4795-A060-2F236D92322DQ34856138-B03FD8BB-8AEE-4774-9F6B-1236C204AD1FQ35020198-EFCAFA30-0F37-4943-ACAC-63B59CD09CC3Q35058245-AD49122B-1F6C-4CF7-8670-0119C7C2FD8AQ35105049-708C6777-56AF-4021-8A8C-7C4A6C4FFCCEQ35122489-4D423BD6-89D9-476A-A27F-8B93C4556A20Q35739600-364D3578-B4CF-42F5-BE34-A8EEBC8B9C1EQ35857460-FABB07F7-2F24-4330-A622-9FBAE4926E33Q35973512-F0AA8CDA-9CDE-4864-817E-A517C3275DCEQ35991173-E8348CE0-07A5-426B-9FD3-36C976044E37Q36647949-A0B1E54D-815D-4F99-A3F7-3EDAFE2522C9Q36879345-F5C843E6-DF8D-4651-8D7F-AE524BD7395FQ37030702-9CB6FB16-6337-46A9-A968-C4139FC92277Q37980142-AFF21888-13F8-4B38-99B7-60B940292FE6Q38607018-431D8CD9-D511-441C-8271-EA79B51A3797Q39652740-5D4F85EC-6C1A-4EB4-B8A5-54779551BFF1Q39685388-217F1FE3-6C9A-432F-89CF-4FE1A311E81EQ40192291-B2ED5A5A-D1E4-4ED7-B553-7249722F8E46Q40423227-BC471119-0626-43EB-A4AD-3FDF5795450D
P2860
The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The gH-gL complex of herpes si ...... e against HSV type 1 challenge
@ast
The gH-gL complex of herpes si ...... e against HSV type 1 challenge
@en
type
label
The gH-gL complex of herpes si ...... e against HSV type 1 challenge
@ast
The gH-gL complex of herpes si ...... e against HSV type 1 challenge
@en
prefLabel
The gH-gL complex of herpes si ...... e against HSV type 1 challenge
@ast
The gH-gL complex of herpes si ...... e against HSV type 1 challenge
@en
P2093
P2860
P1433
P1476
The gH-gL complex of herpes si ...... e against HSV type 1 challenge
@en
P2093
J M Lubinski
M Ponce-de-Leon
R J Eisenberg
P2860
P577
1998-01-01T00:00:00Z